Intrinsic Value

Is MAHLY undervalued or overvalued?

See the intrinsic value estimate for Medipal Holdings Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

MAHLY Intrinsic Value
LOCKED
Unlock
Today vs. history

MAHLY looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with MAHLY’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor MAHLY
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Current Price $18.5
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to MAHLY

Fundamental Analysis

What Medipal Does

Health Care

Medipal Holdings is a Japanese healthcare distributor. It buys prescription medicines and other healthcare products from drug makers and delivers them to pharmacies, hospitals, and clinics. In simple terms, it sits in the middle of the healthcare supply chain and makes sure the right products reach the right medical sites on time.

Headquarters
Japan JP
Employees
13 061
IPO date
Sep 14, 1995
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Medipal Holdings Corp

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one MAHLY stock?

The intrinsic value for Medipal Holdings Corp (MAHLY) under the Base Case is hidden USD.

Is MAHLY stock undervalued or overvalued?

Compared with the current market price of 18.5 USD, the stock appears hidden.

Back to Top